Our average EBITDA margin of 20.5% during our forecast period is 120 basis points ahead of fiscal-year 2024, reaching Sika's fiscal year 2028 target of between 20% to 23% by 2026. The improvement is ...

Analysts are estimating that Abbott Laboratories will report an earnings per share (EPS) of $1.07. The market awaits Abbott Laboratories's announcement, with hopes high for news of surpassing ...

A look back at the best stories and features from the 2025 Australian Grand Prix with Sky's Formula 1 presenters.